Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DMG Italia is an Italian pharmaceutical company headquartered in Pomezia, specializing in the research, development, and commercialization of innovative medical devices and dietary supplements. Founded in 1993, the company has established a robust presence in therapeutic areas such as gastroenterology, otolaryngology (ENT), pediatrics, and ophthalmology. Their flagship portfolio includes widely recognized products like Gastrotuss for the treatment of acid reflux and Rinopanteina for the repair of nasal mucosa. DMG Italia maintains a strong focus on proprietary R&D, holding numerous international patents and manufacturing its products in accordance with high-quality standards. The company operates a global distribution network, providing healthcare solutions to more than 50 countries worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DMG Italia.